[{"address1": "12265 El Camino Real", "address2": "Suite 350", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858 727 1045", "fax": "858 614 7007", "website": "https://www.connectbiopharm.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on developing therapies to treat T cell-driven inflammatory diseases. The company is building a pipeline of small molecules and antibodies using functional T cell assays to screen and discover potent product candidates against validated immune targets. Its lead product candidate is CBP-201, an antibody to target interleukin-4 receptor alpha in development for the treatment of atopic dermatitis (AD) and asthma. The company's product candidates also comprise CBP-307, a modulator of S1P1 T cell receptor and is in development for the treatment of ulcerative colitis; and CBP-174, a peripherally acting antagonist of histamine receptor 3 in development for the treatment of pruritus associated with skin inflammation. Connect Biopharma Holdings Limited was founded in 2012 and is headquartered in San Diego, California.", "fullTimeEmployees": 100, "companyOfficers": [{"maxAge": 1, "name": "Dr. Wubin  Pan M.B.A., Ph.D.", "age": 58, "title": "Co-Founder, President & Chairman of the Board of Directors", "yearBorn": 1965, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Zheng  Wei Ph.D.", "age": 59, "title": "Co-Founder, CEO & Director", "yearBorn": 1964, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steven  Chan", "age": 51, "title": "Chief Financial Officer", "yearBorn": 1972, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jiang  Bian J.D.", "title": "General Counsel & Chief Compliance Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lei  Sun Ph.D.", "age": 59, "title": "VP of Biologics & Head of CMC", "yearBorn": 1964, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Raul  Collazo Ph.D.", "title": "VP & Global Head of Medical Affairs", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Malinda V.  Longphre Ph.D.", "title": "VP & Head of US Clinical Operations", "exercisedValue": 0, "unexercisedValue": 0}], "maxAge": 86400, "priceHint": 4, "previousClose": 1.72, "open": 1.68, "dayLow": 1.63, "dayHigh": 1.8499, "regularMarketPreviousClose": 1.72, "regularMarketOpen": 1.68, "regularMarketDayLow": 1.63, "regularMarketDayHigh": 1.8499, "beta": -0.603, "forwardPE": -3.0925925, "volume": 78451, "regularMarketVolume": 78451, "averageVolume": 164772, "averageVolume10days": 242970, "averageDailyVolume10Day": 242970, "marketCap": 91969568, "fiftyTwoWeekLow": 0.535, "fiftyTwoWeekHigh": 2.84, "fiftyDayAverage": 1.3927, "twoHundredDayAverage": 1.14842, "currency": "USD", "enterpriseValue": -854769472, "floatShares": 16024172, "sharesOutstanding": 55071600, "sharesShort": 115465, "sharesShortPriorMonth": 123662, "sharesShortPreviousMonthDate": 1709164800, "dateShortInterest": 1711584000, "sharesPercentSharesOut": 0.0021, "heldPercentInsiders": 0.41287, "heldPercentInstitutions": 0.44032001, "shortRatio": 1.11, "shortPercentOfFloat": 0.0037, "impliedSharesOutstanding": 55071600, "bookValue": 16.882, "priceToBook": 0.098921925, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1688083200, "netIncomeToCommon": -607734016, "trailingEps": -1.53, "forwardEps": -0.54, "enterpriseToEbitda": 1.423, "52WeekChange": 0.4649123, "SandP52WeekChange": 0.21828604, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "CNTB", "underlyingSymbol": "CNTB", "shortName": "Connect Biopharma Holdings Limi", "longName": "Connect Biopharma Holdings Limited", "firstTradeDateEpochUtc": 1616160600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "f1aecc10-79bf-31c7-a21a-8af27158e95e", "messageBoardId": "finmb_706016439", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.67, "targetHighPrice": 7.0, "targetLowPrice": 6.0, "targetMeanPrice": 6.5, "targetMedianPrice": 6.5, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 951033024, "totalCashPerShare": 17.269, "ebitda": -600856000, "totalDebt": 4294000, "quickRatio": 8.816, "currentRatio": 9.255, "debtToEquity": 0.462, "returnOnAssets": -0.28954, "returnOnEquity": -0.5152, "freeCashflow": -388603744, "operatingCashflow": -552673984, "financialCurrency": "CNY", "trailingPegRatio": null, "__fetch_time": "2024-04-16"}]